Lu et al. [161] demonstrated that thalidomide could effectively prevent skin and pulmonary fibrosis in a mouse model via inhibiting the TGF-β/Smad 3 signaling pathway and rectifying predilection of Th17/Treg balance in SSc. Here, TGFB1 is linked to systemic sclerosis.